Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

First new narcolepsy therapy in decades cleared in U.K.

Oct. 21, 1997

Dexanabinol: pharmacokinetics in humans

Oct. 21, 1997

New formulation of diazepam launched in U.S.

Oct. 21, 1997

Further indications of divalproex efficacy in dementia

Oct. 21, 1997

CoCensys receives NIH grant to develop caspase inhibitors

Oct. 21, 1997

Ginkgo biloba extract stabilizes dementia in patients in U.S. trial

Oct. 21, 1997

Peripheral and Central Nervous System Drugs Advisory Committee meets next month

Oct. 20, 1997

Toyama to begin U.S. development of Alzheimer's drug

Oct. 20, 1997

Warner-Lambert prepares new cyclic amino acids related to gabapentin

Oct. 20, 1997

U-101033E vs. U-74389G in rat model of focal cerebral ischemia

Oct. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...